Plasma-derived product · Immune activation, directed at MERS-CoV spike protein
SAB-301 is a purified human immune globulin G polyclonal antibody that specifically binds the MERS-CoV spike (S) protein, the viral membrane component responsible for attachment to host cells. It is purified from the plasma of immunized transchromosomic bovines and is studied in Middle East Respiratory Syndrome coronavirus infection.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT02788188 | Phase 1 | Middle East Respiratory Syndrome Coronavirus | Completed | SABS |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Middle East Respiratory Syndrome Coronavirus